Loading…

Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells

Hepatocyte growth factor (HGF) activator inhibitor type‐1 (HAI‐1), encoded by the SPINT1 gene, is a transmembrane protease inhibitor that regulates membrane‐anchored serine proteases, particularly matriptase. Here, we explored the role of HAI‐1 in tongue squamous cell carcinoma (TSCC) cells. An immu...

Full description

Saved in:
Bibliographic Details
Published in:Cancer science 2022-06, Vol.113 (6), p.2179-2193
Main Authors: Izumi, Aya, Yamamoto, Koji, Kawaguchi, Makiko, Yamashita, Fumiki, Fukushima, Tsuyoshi, Kiwaki, Takumi, Tanaka, Hiroyuki, Yamashita, Yoshihiro, Kataoka, Hiroaki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c6046-217aa36f647a1b76ae1f7645ed3240a16ebae2f5556f891ef7abd89604d087b23
container_end_page 2193
container_issue 6
container_start_page 2179
container_title Cancer science
container_volume 113
creator Izumi, Aya
Yamamoto, Koji
Kawaguchi, Makiko
Yamashita, Fumiki
Fukushima, Tsuyoshi
Kiwaki, Takumi
Tanaka, Hiroyuki
Yamashita, Yoshihiro
Kataoka, Hiroaki
description Hepatocyte growth factor (HGF) activator inhibitor type‐1 (HAI‐1), encoded by the SPINT1 gene, is a transmembrane protease inhibitor that regulates membrane‐anchored serine proteases, particularly matriptase. Here, we explored the role of HAI‐1 in tongue squamous cell carcinoma (TSCC) cells. An immunohistochemical study of HAI‐1 in surgically resected TSCC revealed the cell surface immunoreactivity of HAI‐1 in the main portion of the tumor. The immunoreactivity decreased in the infiltrative front, and this decrease correlated with enhanced lymphatic invasion as judged by podoplanin immunostaining. In vitro homozygous deletion of SPINT1 (HAI‐1KO) in TSCC cell lines (HSC3 and SAS) suppressed the cell growth rate but significantly enhanced invasion in vitro. The loss of HAI‐1 resulted in enhanced pericellular activities of proteases, such as matriptase and urokinase‐type plasminogen activator, which induced activation of HGF/MET signaling in the co‐culture with pro‐HGF‐expressing fibroblasts and plasminogen‐dependent plasmin generation, respectively. The enhanced plasminogen‐dependent plasmin generation was abrogated partly by matriptase silencing. Culture supernatants of HAI‐1KO cells had enhanced potency for converting the proform of vascular endothelial growth factor‐C (VEGF‐C), a lymphangiogenesis factor, into the mature form in a plasminogen‐dependent manner. Furthermore, HGF significantly stimulated VEGF‐C expression in TSCC cells. Orthotopic xenotransplantation into nude mouse tongue revealed enhanced lymphatic invasion of HAI‐1KO TSCC cells compared to control cells. Our results suggest that HAI‐1 insufficiency leads to dysregulated pericellular protease activity, which eventually orchestrates robust activation of protease‐dependent growth factors, such as HGF and VEGF‐C, in a tumor microenvironment to contribute to TSCC progression. Hepatocyte growth factor (HGF) activator inhibitor type‐1 insufficiency promotes MET phosphorylation and lymphatic invasion of cancer cells in an orthotopic xenotransplantation model when co‐transplanted with pro‐HGF‐producing fibroblasts.
doi_str_mv 10.1111/cas.15346
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9207362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A740914125</galeid><sourcerecordid>A740914125</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6046-217aa36f647a1b76ae1f7645ed3240a16ebae2f5556f891ef7abd89604d087b23</originalsourceid><addsrcrecordid>eNp1ks1u1DAQxyMEoqVw4AVQJC5w2K2_Ym8uSKsVH5UqcQDO1sQ73rhK7MVOtsqNR-AZeRKcbikUgS3ZI89v_uMZTVE8p2RJ8zo3kJa04kI-KE4pF_VCESIf3thqURPOToonKV0RwqWoxePihFecM0nEaXG48Gm01hmH3kxlsGWLexiCmQYsdzFcD21pwQwhlvl0B5gt51vXuGz9-PadliZ4izGV3dTvWxicyf4DJBf8LDcEvxuxNBCN86GH0mDXpafFIwtdwme391nx5d3bz5sPi8uP7y8268uFyb-TC0YVAJdWCgW0URKQWiVFhVvOBAEqsQFktqoqaVc1Raug2a7qHLslK9Uwfla8Oerux6bHrUE_ROj0Proe4qQDOH3f412rd-Gga0YUl7PAq1uBGL6OmAbduzSXAB7DmDSTQhDGVrXI6Mu_0KswRp_Ly5RaMV4TKn9TO-hQO29DzmtmUb1WgtRUUFZlavkPKu8t9i43HK3L7_cCXh8DTAwpRbR3NVKi5yHReUj0zZBk9sWfTbkjf01FBs6PwHXOMv1fSW_Wn46SPwHejsgi</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2678239016</pqid></control><display><type>article</type><title>Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells</title><source>Publicly Available Content Database</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Izumi, Aya ; Yamamoto, Koji ; Kawaguchi, Makiko ; Yamashita, Fumiki ; Fukushima, Tsuyoshi ; Kiwaki, Takumi ; Tanaka, Hiroyuki ; Yamashita, Yoshihiro ; Kataoka, Hiroaki</creator><creatorcontrib>Izumi, Aya ; Yamamoto, Koji ; Kawaguchi, Makiko ; Yamashita, Fumiki ; Fukushima, Tsuyoshi ; Kiwaki, Takumi ; Tanaka, Hiroyuki ; Yamashita, Yoshihiro ; Kataoka, Hiroaki</creatorcontrib><description>Hepatocyte growth factor (HGF) activator inhibitor type‐1 (HAI‐1), encoded by the SPINT1 gene, is a transmembrane protease inhibitor that regulates membrane‐anchored serine proteases, particularly matriptase. Here, we explored the role of HAI‐1 in tongue squamous cell carcinoma (TSCC) cells. An immunohistochemical study of HAI‐1 in surgically resected TSCC revealed the cell surface immunoreactivity of HAI‐1 in the main portion of the tumor. The immunoreactivity decreased in the infiltrative front, and this decrease correlated with enhanced lymphatic invasion as judged by podoplanin immunostaining. In vitro homozygous deletion of SPINT1 (HAI‐1KO) in TSCC cell lines (HSC3 and SAS) suppressed the cell growth rate but significantly enhanced invasion in vitro. The loss of HAI‐1 resulted in enhanced pericellular activities of proteases, such as matriptase and urokinase‐type plasminogen activator, which induced activation of HGF/MET signaling in the co‐culture with pro‐HGF‐expressing fibroblasts and plasminogen‐dependent plasmin generation, respectively. The enhanced plasminogen‐dependent plasmin generation was abrogated partly by matriptase silencing. Culture supernatants of HAI‐1KO cells had enhanced potency for converting the proform of vascular endothelial growth factor‐C (VEGF‐C), a lymphangiogenesis factor, into the mature form in a plasminogen‐dependent manner. Furthermore, HGF significantly stimulated VEGF‐C expression in TSCC cells. Orthotopic xenotransplantation into nude mouse tongue revealed enhanced lymphatic invasion of HAI‐1KO TSCC cells compared to control cells. Our results suggest that HAI‐1 insufficiency leads to dysregulated pericellular protease activity, which eventually orchestrates robust activation of protease‐dependent growth factors, such as HGF and VEGF‐C, in a tumor microenvironment to contribute to TSCC progression. Hepatocyte growth factor (HGF) activator inhibitor type‐1 insufficiency promotes MET phosphorylation and lymphatic invasion of cancer cells in an orthotopic xenotransplantation model when co‐transplanted with pro‐HGF‐producing fibroblasts.</description><identifier>ISSN: 1347-9032</identifier><identifier>EISSN: 1349-7006</identifier><identifier>DOI: 10.1111/cas.15346</identifier><identifier>PMID: 35332604</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>c-Met protein ; Cell culture ; Cell surface ; CRISPR ; Fibroblasts ; Gene deletion ; Genomes ; Growth rate ; HAI‐1 ; Hepatocyte growth factor ; HGF ; Immunohistochemistry ; Immunoreactivity ; Kinases ; Lymphatic system ; matriptase ; Medical research ; Metastasis ; Oral cancer ; oral squamous cell carcinoma ; Original ; Plasmin ; Protease inhibitors ; Proteases ; Proteinase inhibitors ; Proteins ; R&amp;D ; Research &amp; development ; Serine proteinase ; Squamous cell carcinoma ; Surgery ; Tongue ; Tumor microenvironment ; Tumors ; U-Plasminogen activator ; Vascular endothelial growth factor ; VEGF‐C ; Xenografts</subject><ispartof>Cancer science, 2022-06, Vol.113 (6), p.2179-2193</ispartof><rights>2022 The Authors. published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Cancer Association.</rights><rights>2022 The Authors. Cancer Science published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Cancer Association.</rights><rights>COPYRIGHT 2022 John Wiley &amp; Sons, Inc.</rights><rights>2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c6046-217aa36f647a1b76ae1f7645ed3240a16ebae2f5556f891ef7abd89604d087b23</cites><orcidid>0000-0002-9350-777X ; 0000-0001-9948-0451</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2678239016/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2678239016?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35332604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Izumi, Aya</creatorcontrib><creatorcontrib>Yamamoto, Koji</creatorcontrib><creatorcontrib>Kawaguchi, Makiko</creatorcontrib><creatorcontrib>Yamashita, Fumiki</creatorcontrib><creatorcontrib>Fukushima, Tsuyoshi</creatorcontrib><creatorcontrib>Kiwaki, Takumi</creatorcontrib><creatorcontrib>Tanaka, Hiroyuki</creatorcontrib><creatorcontrib>Yamashita, Yoshihiro</creatorcontrib><creatorcontrib>Kataoka, Hiroaki</creatorcontrib><title>Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells</title><title>Cancer science</title><addtitle>Cancer Sci</addtitle><description>Hepatocyte growth factor (HGF) activator inhibitor type‐1 (HAI‐1), encoded by the SPINT1 gene, is a transmembrane protease inhibitor that regulates membrane‐anchored serine proteases, particularly matriptase. Here, we explored the role of HAI‐1 in tongue squamous cell carcinoma (TSCC) cells. An immunohistochemical study of HAI‐1 in surgically resected TSCC revealed the cell surface immunoreactivity of HAI‐1 in the main portion of the tumor. The immunoreactivity decreased in the infiltrative front, and this decrease correlated with enhanced lymphatic invasion as judged by podoplanin immunostaining. In vitro homozygous deletion of SPINT1 (HAI‐1KO) in TSCC cell lines (HSC3 and SAS) suppressed the cell growth rate but significantly enhanced invasion in vitro. The loss of HAI‐1 resulted in enhanced pericellular activities of proteases, such as matriptase and urokinase‐type plasminogen activator, which induced activation of HGF/MET signaling in the co‐culture with pro‐HGF‐expressing fibroblasts and plasminogen‐dependent plasmin generation, respectively. The enhanced plasminogen‐dependent plasmin generation was abrogated partly by matriptase silencing. Culture supernatants of HAI‐1KO cells had enhanced potency for converting the proform of vascular endothelial growth factor‐C (VEGF‐C), a lymphangiogenesis factor, into the mature form in a plasminogen‐dependent manner. Furthermore, HGF significantly stimulated VEGF‐C expression in TSCC cells. Orthotopic xenotransplantation into nude mouse tongue revealed enhanced lymphatic invasion of HAI‐1KO TSCC cells compared to control cells. Our results suggest that HAI‐1 insufficiency leads to dysregulated pericellular protease activity, which eventually orchestrates robust activation of protease‐dependent growth factors, such as HGF and VEGF‐C, in a tumor microenvironment to contribute to TSCC progression. Hepatocyte growth factor (HGF) activator inhibitor type‐1 insufficiency promotes MET phosphorylation and lymphatic invasion of cancer cells in an orthotopic xenotransplantation model when co‐transplanted with pro‐HGF‐producing fibroblasts.</description><subject>c-Met protein</subject><subject>Cell culture</subject><subject>Cell surface</subject><subject>CRISPR</subject><subject>Fibroblasts</subject><subject>Gene deletion</subject><subject>Genomes</subject><subject>Growth rate</subject><subject>HAI‐1</subject><subject>Hepatocyte growth factor</subject><subject>HGF</subject><subject>Immunohistochemistry</subject><subject>Immunoreactivity</subject><subject>Kinases</subject><subject>Lymphatic system</subject><subject>matriptase</subject><subject>Medical research</subject><subject>Metastasis</subject><subject>Oral cancer</subject><subject>oral squamous cell carcinoma</subject><subject>Original</subject><subject>Plasmin</subject><subject>Protease inhibitors</subject><subject>Proteases</subject><subject>Proteinase inhibitors</subject><subject>Proteins</subject><subject>R&amp;D</subject><subject>Research &amp; development</subject><subject>Serine proteinase</subject><subject>Squamous cell carcinoma</subject><subject>Surgery</subject><subject>Tongue</subject><subject>Tumor microenvironment</subject><subject>Tumors</subject><subject>U-Plasminogen activator</subject><subject>Vascular endothelial growth factor</subject><subject>VEGF‐C</subject><subject>Xenografts</subject><issn>1347-9032</issn><issn>1349-7006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNp1ks1u1DAQxyMEoqVw4AVQJC5w2K2_Ym8uSKsVH5UqcQDO1sQ73rhK7MVOtsqNR-AZeRKcbikUgS3ZI89v_uMZTVE8p2RJ8zo3kJa04kI-KE4pF_VCESIf3thqURPOToonKV0RwqWoxePihFecM0nEaXG48Gm01hmH3kxlsGWLexiCmQYsdzFcD21pwQwhlvl0B5gt51vXuGz9-PadliZ4izGV3dTvWxicyf4DJBf8LDcEvxuxNBCN86GH0mDXpafFIwtdwme391nx5d3bz5sPi8uP7y8268uFyb-TC0YVAJdWCgW0URKQWiVFhVvOBAEqsQFktqoqaVc1Raug2a7qHLslK9Uwfla8Oerux6bHrUE_ROj0Proe4qQDOH3f412rd-Gga0YUl7PAq1uBGL6OmAbduzSXAB7DmDSTQhDGVrXI6Mu_0KswRp_Ly5RaMV4TKn9TO-hQO29DzmtmUb1WgtRUUFZlavkPKu8t9i43HK3L7_cCXh8DTAwpRbR3NVKi5yHReUj0zZBk9sWfTbkjf01FBs6PwHXOMv1fSW_Wn46SPwHejsgi</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Izumi, Aya</creator><creator>Yamamoto, Koji</creator><creator>Kawaguchi, Makiko</creator><creator>Yamashita, Fumiki</creator><creator>Fukushima, Tsuyoshi</creator><creator>Kiwaki, Takumi</creator><creator>Tanaka, Hiroyuki</creator><creator>Yamashita, Yoshihiro</creator><creator>Kataoka, Hiroaki</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9350-777X</orcidid><orcidid>https://orcid.org/0000-0001-9948-0451</orcidid></search><sort><creationdate>202206</creationdate><title>Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells</title><author>Izumi, Aya ; Yamamoto, Koji ; Kawaguchi, Makiko ; Yamashita, Fumiki ; Fukushima, Tsuyoshi ; Kiwaki, Takumi ; Tanaka, Hiroyuki ; Yamashita, Yoshihiro ; Kataoka, Hiroaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6046-217aa36f647a1b76ae1f7645ed3240a16ebae2f5556f891ef7abd89604d087b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>c-Met protein</topic><topic>Cell culture</topic><topic>Cell surface</topic><topic>CRISPR</topic><topic>Fibroblasts</topic><topic>Gene deletion</topic><topic>Genomes</topic><topic>Growth rate</topic><topic>HAI‐1</topic><topic>Hepatocyte growth factor</topic><topic>HGF</topic><topic>Immunohistochemistry</topic><topic>Immunoreactivity</topic><topic>Kinases</topic><topic>Lymphatic system</topic><topic>matriptase</topic><topic>Medical research</topic><topic>Metastasis</topic><topic>Oral cancer</topic><topic>oral squamous cell carcinoma</topic><topic>Original</topic><topic>Plasmin</topic><topic>Protease inhibitors</topic><topic>Proteases</topic><topic>Proteinase inhibitors</topic><topic>Proteins</topic><topic>R&amp;D</topic><topic>Research &amp; development</topic><topic>Serine proteinase</topic><topic>Squamous cell carcinoma</topic><topic>Surgery</topic><topic>Tongue</topic><topic>Tumor microenvironment</topic><topic>Tumors</topic><topic>U-Plasminogen activator</topic><topic>Vascular endothelial growth factor</topic><topic>VEGF‐C</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Izumi, Aya</creatorcontrib><creatorcontrib>Yamamoto, Koji</creatorcontrib><creatorcontrib>Kawaguchi, Makiko</creatorcontrib><creatorcontrib>Yamashita, Fumiki</creatorcontrib><creatorcontrib>Fukushima, Tsuyoshi</creatorcontrib><creatorcontrib>Kiwaki, Takumi</creatorcontrib><creatorcontrib>Tanaka, Hiroyuki</creatorcontrib><creatorcontrib>Yamashita, Yoshihiro</creatorcontrib><creatorcontrib>Kataoka, Hiroaki</creatorcontrib><collection>Wiley Open Access</collection><collection>Wiley-Blackwell Backfiles (Open access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Izumi, Aya</au><au>Yamamoto, Koji</au><au>Kawaguchi, Makiko</au><au>Yamashita, Fumiki</au><au>Fukushima, Tsuyoshi</au><au>Kiwaki, Takumi</au><au>Tanaka, Hiroyuki</au><au>Yamashita, Yoshihiro</au><au>Kataoka, Hiroaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells</atitle><jtitle>Cancer science</jtitle><addtitle>Cancer Sci</addtitle><date>2022-06</date><risdate>2022</risdate><volume>113</volume><issue>6</issue><spage>2179</spage><epage>2193</epage><pages>2179-2193</pages><issn>1347-9032</issn><eissn>1349-7006</eissn><abstract>Hepatocyte growth factor (HGF) activator inhibitor type‐1 (HAI‐1), encoded by the SPINT1 gene, is a transmembrane protease inhibitor that regulates membrane‐anchored serine proteases, particularly matriptase. Here, we explored the role of HAI‐1 in tongue squamous cell carcinoma (TSCC) cells. An immunohistochemical study of HAI‐1 in surgically resected TSCC revealed the cell surface immunoreactivity of HAI‐1 in the main portion of the tumor. The immunoreactivity decreased in the infiltrative front, and this decrease correlated with enhanced lymphatic invasion as judged by podoplanin immunostaining. In vitro homozygous deletion of SPINT1 (HAI‐1KO) in TSCC cell lines (HSC3 and SAS) suppressed the cell growth rate but significantly enhanced invasion in vitro. The loss of HAI‐1 resulted in enhanced pericellular activities of proteases, such as matriptase and urokinase‐type plasminogen activator, which induced activation of HGF/MET signaling in the co‐culture with pro‐HGF‐expressing fibroblasts and plasminogen‐dependent plasmin generation, respectively. The enhanced plasminogen‐dependent plasmin generation was abrogated partly by matriptase silencing. Culture supernatants of HAI‐1KO cells had enhanced potency for converting the proform of vascular endothelial growth factor‐C (VEGF‐C), a lymphangiogenesis factor, into the mature form in a plasminogen‐dependent manner. Furthermore, HGF significantly stimulated VEGF‐C expression in TSCC cells. Orthotopic xenotransplantation into nude mouse tongue revealed enhanced lymphatic invasion of HAI‐1KO TSCC cells compared to control cells. Our results suggest that HAI‐1 insufficiency leads to dysregulated pericellular protease activity, which eventually orchestrates robust activation of protease‐dependent growth factors, such as HGF and VEGF‐C, in a tumor microenvironment to contribute to TSCC progression. Hepatocyte growth factor (HGF) activator inhibitor type‐1 insufficiency promotes MET phosphorylation and lymphatic invasion of cancer cells in an orthotopic xenotransplantation model when co‐transplanted with pro‐HGF‐producing fibroblasts.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>35332604</pmid><doi>10.1111/cas.15346</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-9350-777X</orcidid><orcidid>https://orcid.org/0000-0001-9948-0451</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1347-9032
ispartof Cancer science, 2022-06, Vol.113 (6), p.2179-2193
issn 1347-9032
1349-7006
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9207362
source Publicly Available Content Database; Wiley Open Access; PubMed Central
subjects c-Met protein
Cell culture
Cell surface
CRISPR
Fibroblasts
Gene deletion
Genomes
Growth rate
HAI‐1
Hepatocyte growth factor
HGF
Immunohistochemistry
Immunoreactivity
Kinases
Lymphatic system
matriptase
Medical research
Metastasis
Oral cancer
oral squamous cell carcinoma
Original
Plasmin
Protease inhibitors
Proteases
Proteinase inhibitors
Proteins
R&D
Research & development
Serine proteinase
Squamous cell carcinoma
Surgery
Tongue
Tumor microenvironment
Tumors
U-Plasminogen activator
Vascular endothelial growth factor
VEGF‐C
Xenografts
title Insufficiency of hepatocyte growth factor activator inhibitor‐1 confers lymphatic invasion of tongue carcinoma cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A14%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insufficiency%20of%20hepatocyte%20growth%20factor%20activator%20inhibitor%E2%80%901%20confers%20lymphatic%20invasion%20of%20tongue%20carcinoma%20cells&rft.jtitle=Cancer%20science&rft.au=Izumi,%20Aya&rft.date=2022-06&rft.volume=113&rft.issue=6&rft.spage=2179&rft.epage=2193&rft.pages=2179-2193&rft.issn=1347-9032&rft.eissn=1349-7006&rft_id=info:doi/10.1111/cas.15346&rft_dat=%3Cgale_pubme%3EA740914125%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6046-217aa36f647a1b76ae1f7645ed3240a16ebae2f5556f891ef7abd89604d087b23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2678239016&rft_id=info:pmid/35332604&rft_galeid=A740914125&rfr_iscdi=true